Nokia Corporation (NOK) Call Players Take Charge

Nokia Corporation's (ADR) (NYSE:NOK) back-month calls are in focus today

by Karee Venema

Published on May 26, 2015 at 2:48 PM

Call players have taken charge of Nokia Corporation's (ADR) (NYSE:NOK) options pits today. By the numbers, 5,104 calls have changed hands thus far, compared to fewer than 550 puts.

Seeing the most action is NOK's July 8 call, where it appears new positions are being purchased. If traders are indeed buying to open the calls, the goal is for the security to muscle north of $8 by the close on Friday, July 17 -- when the back-month options expire. Delta on the call is docked at 0.20, indicating a 1-in-5 chance of an in-the-money finish.

Expanding the sentiment scope reveals put buyers have been active in NOK's options arena in recent weeks. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the equity's 10-day put/call volume ratio of 0.67 sits just 10 percentage points from a 52-week peak.

Technically speaking, the withstanding skepticism among option traders more closely aligns to NOK's technical trajectory. Year-to-date, the shares have lost almost 9% to trade at $7.16. More recently, the stock made an attempt to fill its late-April earnings-induced bear gap, but was quickly halted by its descending 40-day moving average.

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.
Wall Street Roars Higher Amid Civil Unrest
Investors weighed a mixed bag of jobs data
AstraZeneca Stock Flat Despite COVID-19 Vaccine News
AstraZeneca saw a rise in capacity for its COVID-19 vaccine candidate
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.